Navigation Links
55th annual meeting of the Health Physics Society
Date:6/17/2010

McLean, VA, June 15, 2010 "The Future of the Nuclear Industry" will be the Plenary Session topic of the 55th Annual Meeting of the Health Physics Society (HPS) taking place June 28-July 1, 2010, at the Salt Palace Convention Center in Salt Lake City, UT. The Honorable Gregory D. Jaczko, Chair of the Nuclear Regulatory Commission, will be the lead presenter of the opening session on June 28 at 8:30 a.m.

Over 250 presentations between June 28 and July 1 will occur at the HPS Annual Meeting with topics that range from radiological incident consequence management to the National Cancer Institute dosimetry studies.

Highlights:

Monday afternoon

  • More power reactor information
  • Public perspective of risk
  • Low-level radioactive waste site monitoring

Tuesday (all day)

  • Radiation dose reconstruction
    • Radium dial painters
    • Japanese bomb survivors
    • 15-Country worker study
    • Radiologic technologists
    • Russian sites Chernobyl, Mayak and Techa River

Wednesday morning

  • Radiological incident consequence management
    • The Federal Radiation Monitoring & Assessment Center
    • Mobile detection systems
    • Individual retrospective dosimetry
    • The Empire-09 exercise Albany response to a dirty bomb

Wednesday afternoon

  • Military Health Physics
    • Intentional poisonings with radioactive materials
    • Medical implications of enhanced radiation weapons
  • NRC stakeholder workshop on radiation safety culture

Thursday morning

  • Medical
    • Radioisotope production in the United States
    • Federal guidance for radiography
    • CT radiation dose reduction
  • NCI dosimetry studies
    • Pacific nuclear testing fallout on Bikini and Enewetak
    • Nuclear tests in Kazakhstan
    • Mammography doses


'/>"/>

Contact: Kelly Classic
media@hps.org
507-284-4407
Health Physics Society
Source:Eurekalert

Related biology news :

1. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
2. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
3. Colony collapse disorder symposium added to ESA Annual Meeting
4. Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings
5. Canadian Society of Exercise Physiology Annual Scientific Conference
6. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
7. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
8. Oceanographer Dennis J. McGillicuddy, Jr. receives 34th annual Rosenstiel Award
9. Cell biologists announce child-care grants for scientist-parents at annual meeting
10. 5th annual Keys bonefish population census results announced
11. 5th Annual World Health Care Congress April 21-23, Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute announced ... Larry Schlesinger as the Institute,s new President and ... effective May 31, 2017. He is currently the Chair of ... the Center for Microbial Interface Biology at Ohio State University. ... the new President and CEO of Texas Biomed," said Dr. ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent ... availability of a new report, Sensors for Robotics: Technologies, Markets ... ... ... IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  If only one ... had a mutation-conferring resistance to chemotherapy, thousands of ... research has focused on finding these mutations in ... from circulating tumor DNA in blood — to ... therapeutics. Unfortunately, however, detecting these genetic ...
(Date:2/16/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company ... better treatment for triple negative breast cancer (TNBC), announced today ... program. The YEi Start in ... help entrepreneurs grow their business in France ... companies selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... LOS ANGELES , Feb. 16, 2017 /PRNewswire/ ... CAPR ), a clinical-stage biotechnology company developing first-in-class ... today announced that it has elected to terminate ... to natriuretic peptide receptor agonists, including Cenderitide. ... a strategic move as we prioritize our efforts ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology: